<DOC>
	<DOCNO>NCT01587976</DOCNO>
	<brief_summary>The purpose trial study health relate quality life ( HQoL ) resection colorectal liver metastasis combine perioperative chemotherapy . The investigator want study aggressive , life prolong multimodal treatment defend quality life perspective .</brief_summary>
	<brief_title>Health Related Quality Life After Surgery Oncological Treatment Colorectal Liver Metastases</brief_title>
	<detailed_description>Background : Hepatic resection treatment potential curative intent patient colorectal liver metastasis . Combined chemotherapy , overall 5-year survival 40-50 % . The disease free 5-year survival 20 % , 70 % resected patient experience recurrence disease . Even surgery superior treatment , patient finally die cancer . However ; surgery contribute add year life , minority , disease free life . There much effort study predictor outcome surgery , little focused quality life follow treatment . Method : EORTC Validated questionnaire ( European Organisation Research Treatment Cancer ) version QLQ-C30 ( 3.0 ) QLQ LMC21 . The patient fill questionnaire surgery baseline , 3,6 12 month surgery . The investigator also register important clinicopathological data patient prospectively .</detailed_description>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Neoplasms , Second Primary</mesh_term>
	<criteria>Liver metastasis colorectal cancer Resectability , intension R0 resection No macroscopic tumor leave surgery Patients combine resectable extrahepatic tumor also include . Patients must complete questionnaire operation . Drop questionnaire surgery Patients find irresectable operation macroscopic tumor tissue leave behind .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>Health related quality life</keyword>
	<keyword>Colorectal liver metastasis</keyword>
	<keyword>surveillance</keyword>
</DOC>